IE42043L - Influenza type b virus vaccines. - Google Patents

Influenza type b virus vaccines.

Info

Publication number
IE42043L
IE42043L IE750160A IE16075A IE42043L IE 42043 L IE42043 L IE 42043L IE 750160 A IE750160 A IE 750160A IE 16075 A IE16075 A IE 16075A IE 42043 L IE42043 L IE 42043L
Authority
IE
Ireland
Prior art keywords
strain
attenuated
recombinant
influenza type
virus
Prior art date
Application number
IE750160A
Other versions
IE42043B1 (en
Original Assignee
Rech Et Ind Therapeutics Rit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rech Et Ind Therapeutics Rit filed Critical Rech Et Ind Therapeutics Rit
Publication of IE42043L publication Critical patent/IE42043L/en
Publication of IE42043B1 publication Critical patent/IE42043B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

1439742 Nasal influenza vaccine RECHERCHE ET INDUSTRIE THERAPEUTIQUES 3 Feb 1975 [4 Feb 1974] 4535/75 Heading A5B A live influenza virus vaccine suitable for nasal administration comprises, as active ingredient an attenuated influenza type B virus strain recombinant obtained from (i) a vaccinal and attenuated influenza type B virus strain and (ii) another influenza type B virus strain, said recombinant having at least one marker property of said attenuated strain which is not shared by said other strain and the antigenic composition of said other strain. The attenuated strain may be Brigit strain. The recombinant may be influenza type BR5, R22 or R22 strain (ATCC VR787, 788 and 789 respectively). The recombinant may be prepared by combining the attenuated strain and the other strain in the allantoic cavity of embryonated chicken eggs, and isolating the recombinant by selective pressure. The isolate may be grown in the allantoic cavity of chicken eggs, admixed with a stabilizer, e.g. peptone or sugar, and freeze-dried. The vaccine may also include an attenuated influenza type A virus vaccine, e.g. Alice strain (ATCC VR776). [GB1439742A]
IE160/75A 1974-02-04 1975-01-27 Influenza type b virus vaccines and preparation thereof IE42043B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43917674A 1974-02-04 1974-02-04

Publications (2)

Publication Number Publication Date
IE42043L true IE42043L (en) 1975-08-04
IE42043B1 IE42043B1 (en) 1980-05-21

Family

ID=23743623

Family Applications (1)

Application Number Title Priority Date Filing Date
IE160/75A IE42043B1 (en) 1974-02-04 1975-01-27 Influenza type b virus vaccines and preparation thereof

Country Status (21)

Country Link
JP (1) JPS50107122A (en)
AT (1) AT338416B (en)
BE (1) BE824970A (en)
CA (1) CA1047922A (en)
CH (1) CH596316A5 (en)
CS (1) CS202545B2 (en)
DD (1) DD116474A5 (en)
DE (1) DE2504373A1 (en)
DK (1) DK141926B (en)
ES (1) ES434384A1 (en)
FI (1) FI750260A (en)
FR (1) FR2259616B1 (en)
GB (1) GB1439742A (en)
HU (1) HU170522B (en)
IE (1) IE42043B1 (en)
IL (1) IL46446A (en)
LU (1) LU71784A1 (en)
NL (1) NL7501028A (en)
NO (1) NO750295L (en)
SE (1) SE424503B (en)
ZA (1) ZA75248B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2588918A (en) * 1947-11-07 1952-03-11 William T Graham Mechanism for raising and lowering plow frames relative to the ground wheels
JPS6042209B2 (en) * 1974-05-31 1985-09-20 北里研究所(社団法人) A method for acclimating fresh influenza virus isolates to embryonated chicken eggs in a short period of time

Also Published As

Publication number Publication date
FR2259616B1 (en) 1980-01-04
SE424503B (en) 1982-07-26
NL7501028A (en) 1975-08-06
AU7734675A (en) 1976-07-15
CA1047922A (en) 1979-02-06
FI750260A (en) 1975-08-05
IL46446A (en) 1978-01-31
FR2259616A1 (en) 1975-08-29
IE42043B1 (en) 1980-05-21
CH596316A5 (en) 1978-03-15
GB1439742A (en) 1976-06-16
DK141926C (en) 1981-01-19
JPS50107122A (en) 1975-08-23
AT338416B (en) 1977-08-25
CS202545B2 (en) 1981-01-30
DK9775A (en) 1975-09-29
ATA76675A (en) 1976-12-15
SE7500549L (en) 1975-08-05
DD116474A5 (en) 1975-11-20
LU71784A1 (en) 1975-06-24
DE2504373A1 (en) 1975-08-07
DK141926B (en) 1980-07-21
HU170522B (en) 1977-06-28
ZA75248B (en) 1976-01-28
ES434384A1 (en) 1976-12-01
BE824970A (en) 1975-07-30
NO750295L (en) 1975-09-01
IL46446A0 (en) 1975-04-25

Similar Documents

Publication Publication Date Title
Skeeles et al. Immunization studies with a cell-culture-adapted infectious bursal disease virus
IE38825B1 (en) Stable viral preparations
IE802225L (en) Vaccine stabilizer
HK37397A (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
AU4622693A (en) Potentiation of immunogenic response
CA2134835A1 (en) Live in ovo vaccine
GB1183506A (en) New vaccines for combating influenza and the preparation thereof
IE780811L (en) Vaccine against newcastle disease
TW340873B (en) Chicken anaemia agent vaccine
JPS5527178A (en) Live influenza virus vaccine
IE42043L (en) Influenza type b virus vaccines.
WO1999053950A3 (en) Live vaccines and methods of treatment therewith
IL41902A (en) Immunogenic substance,its production,vaccine preparations containing it and their preparation
CA2224309A1 (en) Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection
DE69328341T2 (en) Vaccine against infectious bursal disease
GB1461188A (en) Live influenza virus vaccines and preparation thereof
KR20000069501A (en) In ovo vaccination against Newcastle Disease
Clark et al. A comparison of live and inactivated influenza A (H1N1) virus vaccines: Short-term immunity
Foege et al. Mass vaccination programs in developing countries
ES432385A1 (en) Influenza vaccines
EP0351908B1 (en) Live newcastle disease virus vacccines
AU6258480A (en) Prep" of influenza virus strains and vaccines
EP0338437A3 (en) Synthetic vaccins against foot and mouth disease and their preparation process
HU205265B (en) Process for producing living vaccine combinations againstvirus infections of fowls
GB680788A (en) Pharmaceutical products